Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Practicing Pathology in the Era of Big Data and Personalized Medicine

Practicing Pathology in the Era of Big Data and Personalized Medicine REVIEW ARTICLE Practicing Pathology in the Era of Big Data and Personalized Medicine Jiang Gu, MD, PhD* and Clive R. Taylor, MD, D Philw morphologic classification, genomics, proteomics, metab- Abstract: The traditional task of the pathologist is to assist olomics, liquid morphology physicians in making the correct diagnosis of diseases at the (Appl Immunohistochem Mol Morphol 2014;22:1–9) earliest possible stage to effectuate the optimal treatment strat- egy for each individual patient. In this respect surgical patho- logy (the traditional tissue diagnosis) is but a tool. It is not, of itself, the purpose of pathology practice; and change is in the air. This January 2014 issue of Applied Immunohistochemistry and THE COMING ERA OF “BIG DATA” AND Molecular Morphology (AIMM) embraces that change by the PERSONALIZED MEDICINE incorporation of the agenda and content of the journal Diag- The last decade has witnessed remarkable progress nostic Molecular Morphology (DMP). Over a decade ago in the area of genomic research that will, in turn, have a AIMM introduced and promoted the concept of “molecular direct impact on pathology and pathologic practice. The morphology,” and has sought to publish molecular studies that progress of pathology as a discipline has always been correlate with http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Applied Immunohistochemistry & Molecular Morphology Wolters Kluwer Health

Practicing Pathology in the Era of Big Data and Personalized Medicine

Loading next page...
 
/lp/wolters-kluwer-health/practicing-pathology-in-the-era-of-big-data-and-personalized-medicine-1HCQPxvA3C
Copyright
Copyright © 2013 by Lippincott Williams & Wilkins
ISSN
1541-2016
eISSN
1533-4058
DOI
10.1097/PAI.0000000000000022
pmid
24326463
Publisher site
See Article on Publisher Site

Abstract

REVIEW ARTICLE Practicing Pathology in the Era of Big Data and Personalized Medicine Jiang Gu, MD, PhD* and Clive R. Taylor, MD, D Philw morphologic classification, genomics, proteomics, metab- Abstract: The traditional task of the pathologist is to assist olomics, liquid morphology physicians in making the correct diagnosis of diseases at the (Appl Immunohistochem Mol Morphol 2014;22:1–9) earliest possible stage to effectuate the optimal treatment strat- egy for each individual patient. In this respect surgical patho- logy (the traditional tissue diagnosis) is but a tool. It is not, of itself, the purpose of pathology practice; and change is in the air. This January 2014 issue of Applied Immunohistochemistry and THE COMING ERA OF “BIG DATA” AND Molecular Morphology (AIMM) embraces that change by the PERSONALIZED MEDICINE incorporation of the agenda and content of the journal Diag- The last decade has witnessed remarkable progress nostic Molecular Morphology (DMP). Over a decade ago in the area of genomic research that will, in turn, have a AIMM introduced and promoted the concept of “molecular direct impact on pathology and pathologic practice. The morphology,” and has sought to publish molecular studies that progress of pathology as a discipline has always been correlate with

Journal

Applied Immunohistochemistry & Molecular MorphologyWolters Kluwer Health

Published: Jan 1, 2014

There are no references for this article.